Keytruda injection, also known by its generic name pembrolizumab, is a medication used to treat various types of cancer. It belongs to a class of drugs called monoclonal antibodies, which are essentially engineered proteins designed to target specific molecules. In the case of Keytruda, it targets a protein called PD-1, which is found in immune cells and some cancer cells.
